Navigation Links
U of M part of $185 million funded team tasked to improve global response to emerging pandemics
Date:10/30/2009

ll lead the RESPOND team, in partnership with the University of Minnesota and Tufts University in Medford, Massachusetts another key member of the cooperative.

Although members of the RESPOND team will be dealing with diseases that don't yet exist, examples of similar diseases they might try to prevent include SARS, Ebola, and avian influenza.

"USAID recognizes the critical need to address emerging illnesses from a global perspective, and to better understand the intersection between human and animal health," said Minnesota Congresswoman Betty McCollum, founder of the Congressional Global Health Caucus. "With this project, USAID recognizes the unique leadership role the University of Minnesota plays in bringing together the multiple disciplines and expertise required to address this global challenge."

The College of Veterinary Medicine's new Ecosystem Health program, National Center for Food Protection and Defense, and Center for Animal Health and Food Safety were instrumental in obtaining funds to join RESPOND.

"We are increasingly aware that our health depends on the health of livestock, wildlife, and the environment," said Katey Pelican, D.V.M., Ph.D., who championed University of Minnesota's proposal effort to join the DAI/RESPOND team and is the head of the Ecosystem Health program. "Nowhere is this clearer than in the increasing number of diseases that are emerging from animal populations as environmental degradation forces more interactions between wildlife, livestock and humans. The RESPOND program will provide the University of Minnesota the opportunity to use its unique ability to work across animal and human health disciplines to improve global response to these life-threatening outbreaks."

Over the course of the five-year project, the RESPOND team will work to improve the training and response capacity for zoonotic disease outbreak identification, investigation, analysis, and control within countries and regi
'/>"/>

Contact: Nick Hanson
hans2853@umn.edu
612-624-2449
University of Minnesota
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
2. AUDIO from Medialink and Pfizer: Number of Uninsured Americans Grows to 47 Million
3. Majority of 2.4 Million U.S. Children With ADHD Not Diagnosed or Consistently Treated, According to New Gold Standard Study by Cincinnati Childrens Researchers
4. 1.5 million children could be saved
5. The Philadelphia Walk Now for Autism Expected to Draw 10,000 Walkers and Raise $1 Million to Help Find Answers About the Nations Fastest-Growing Developmental Disorder
6. UVa researcher awarded $3.6 million grant to fight drug-resistant bacteria
7. EaglePicher Corporation Completes Transaction to Sell EaglePicher Boron, LLC to Ceradyne, Inc. for $69 Million
8. R. P. Simmons Family Foundation Pledges $2 Million for New Childrens Hospital of Pittsburgh of UPMC Campus
9. £5 million investment in personalized medicines to cut patient deaths
10. Keane Wins $1 Million Electronic Medical Record (EMR) Implementation at New Jersey-Based Acute Care Facility
11. PainCare Receives $14.4 Million in Cash From Completed Sale of South Florida Ambulatory Surgery Centers

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...v.25/PRNewswire/-SentinelleMedicalInc.,aleadingman...oftwarelaunchesasuiteofnewleadingedgeclinicalappli...matthisyear,sRadiologicalSocietyofNorthAmerica(RSN...00,HallA).Theapplicationsleveragetheuniquehighqual...ingcoilsandsupportmultipleimagingmodalitiesformult...
(Date:11/25/2009)...,Nov.25/PRNewswire-USNewswire/--TheBlackAIDSInstit...executiveleadershipfor2010. ,, ThenewBoardMembe...publicpolicy,law,finance,governmenthealthprograms,...comesfromawiderangeofpersonalbackgroundsincludingb...thHIVthemselves,andrepresentingmultipleagegroups. ...
(Date:11/25/2009)...ors of testicular cancer who were treated with cis...ects, including neurological side effects and Rayn...with chemotherapy, according to a new study publis...onal Cancer Institute . , Marianne Brydy, M.D., ...y Hospital, in Bergen, Norway, and colleagues cond...
(Date:11/25/2009)...ease blood pressure? This simple question has bee...ew Stress-related gene Modulates High Blood Pressu...sure? This simple question has been the focus of ... has for the first time established a link between...esponse to stress in mice as well as humans. The s...
(Date:11/25/2009)... Evaluation and treatment clinics to resume...ock (Vocus) November 25, 2009 -- Centegra Health S...nd H1N1 vaccine shots at four Centegra Primary Car... of vaccine has arrived. The clinics are at CPC si...y and will be open as follows: ,   Fro...
Breaking Medicine News(10 mins):Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 3Health News:Black AIDS Institute Announces 2010 Board Election Results 2Health News:New stress-related gene modulates high blood pressure in mice and men 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 4
...ournal Health Psychology, by the American Psycholo...with a short temper or mean disposition tend to h...sted even after asthma and smoking were ruled out ...onary Artery Risk Development in (Young) Adults St...
...and a radiation oncologist at Memorial Sloan-Kette... physician patients see can influence the type of...ed men with localized prostate cancer. It found th...a radiation oncologist and an urologist, usually r...
... of Clinical Oncology today, the results of a larg...undwork for decisions that included when or if a ... In patients with metastatic colorectal ca...s necessary. Few studies have examined the...
..., even if it is all subtle, as in Canada apparentl...ard to pin down is more dangerous to mental health...of 180 Korean immigrants living in Canada. ...d author Samuel Noh, professor of psychiatry at th...
...ase, a pair of young US researchers say. The more ...marriage . And never mind the quality of marital l...m Adrianne Frech, a sociology graduate student at ...for depression once in either 1987 or 1988 and the...
...ganizations (AAPPO) is launching a new initiative ...re to those patients diagnosed with diabetes as w...isease. An industry leader, AAPPO today kicked off...iabetes by providing tools and information to the ...
Other Medicine News:Health News:Unhealthy Lungs Linked to Hostility? 2Health News:Early Prostate Cancer: Specialty of Physician Influences Type of Therapy Received 2Health News:Early Prostate Cancer: Specialty of Physician Influences Type of Therapy Received 3Health News:Change in Course of Treatment: Exploring Better Ways 2Health News:Koreans in Canada Feel Put Down by Subtle Racism 2Health News:Marriage Could Lift One Out of Depression, New Study 2Health News:AAPPO Launches ACT on Diabetes Initiative to Promote Improved Diabetes Care 2
(Date:11/25/2009)...MINGHAM,Mass.andSYDNEY,Nov.25/PRNewswire-FirstCall...IN),aleadinginnovatorandprovideroflessinvasive,min...zingthetreatmentofadvancedheartfailure,todayannoun...the21stAnnualPiperJaffrayHealthCareConferenceat8:0...ingheldattheNewYorkPalaceHotel,December1-2. ,, ...
(Date:11/24/2009)...HESDA,Md.,Nov.24/PRNewswire-Asia/--ChindexInternat...pendentAmericanproviderofWestern,healthcareproduct...ouncedthattheCompanywillattendthe21stAnnualPiperJa...mber1-2,2009,atthe,NewYorkPalaceHotel. , Mana...esday,December1,2009,andholdone-on-onemeetingsthr...
(Date:11/24/2009)...INE,Calif.,Nov.24/PRNewswire-FirstCall/--Endologix...reatmentsforaorticdisorders,announcedtodaythatitha...thepatentinfringementlawsuitbroughtagainstitinOcto...esDistrictCourtinIndianapolis,Indiana. ,, Endol...nitedStatesPatentandTrademarkOffice(USPTO)conducts...
Breaking Medicine Technology:Chindex International to Present at Piper Jaffray Health Care Conference 2Endologix Files Motion to Discontinue Court Proceedings Related to Alleged Patent Infringement 2The Leapfrog Group Announces New Board Chair 50087 1The Leapfrog Group Announces New Board Chair 50087 2The Leapfrog Group Announces New Board Chair 50087 3Wrigley Honored With 2009 Best Employers for Healthy Lifestyles Award 50084 1Wrigley Honored With 2009 Best Employers for Healthy Lifestyles Award 50084 2Wrigley Honored With 2009 Best Employers for Healthy Lifestyles Award 50084 3Wrigley Honored With 2009 Best Employers for Healthy Lifestyles Award 50084 4Supply of Key Childrens Vaccine Almost Back to Normal 50081 1Supply of Key Childrens Vaccine Almost Back to Normal 50081 2Supply of Key Childrens Vaccine Almost Back to Normal 50081 3
...NESS WIRE)--May 17, 2007 - Results,published this ...er,vaccine, GARDASIL (Quadrivalent Human Papilloma...as 100 percent effective in,preventing high-grade ...16 and 18, two types strongly associated with thes...d in women who were not,infected with HPV types ta...
...th International Symposium on,Myelodysplastic Synd...ew updated results,from a pivotal Phase II trial e...lood cancer known as myelodysplastic syndromes (MD... H. Lee Moffitt,Cancer Center & Research Insti...rrently taking place in Florence, Italy.,Breakthro...
Other Medicine Technology:Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 2Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 3Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 4Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 5Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 6Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 7Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 8Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 9Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 10Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 11Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 12Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 13Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 14Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 15Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 16Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 17Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 18Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 19Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 20Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 21Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 22Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 23Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 24Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 25Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 26Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 27Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 28Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 29Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 30Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 31Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 32Study Continues to Show Patients With Myelodysplastic Syndromes,Treated With Revlimid are Living Longer and Remaining Transfusion,Independent 2Study Continues to Show Patients With Myelodysplastic Syndromes,Treated With Revlimid are Living Longer and Remaining Transfusion,Independent 3
...higher risk diabetic patient, the PneumaticWalker ...iabetics. Similar to the PneumaticWalker, the Pneu...ve dual density insole to eliminate pressure point...shell and full aircell coverage, also helps regula...
...ce is designed for the treatment of diaphyseal fra...rovides post operative support following intra m...al fixation. The brace allows for movement of join...ascularity and encouraging bone growth. For a more...
...tem for the treatment of injuries of the lower leg...forms to the patient's anatomy and in conjunction ...ilization. As the general time of fracture or rupt...es of treatment can be altered significantly. Exce...
...nefits of controlled compression to minimize hemar...he cuff is anatomically designed to completely fit...o/Cuffs can be ordered as a single cuff, or with a...disk). The Cooler is available separately and can ...
Medicine Products: